MedTrace Logo

TOBI to Monitor Response to Neoadjuvant Therapy in Breast Cancer

NCT00783757 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-07-27

No results posted yet for this study

Summary

The purpose of this research study is to see if Near-Infrared Tomographic Optical Breast Imaging (TOBI) scans can help monitor breast tumor response during treatment for breast cancer. The images created by the TOBI scan show changes in blood blow and oxygen levels in breast tissue.

Conditions

Interventions

DEVICE

Optical Imaging

TOBI scan performed before the participant starts cancer treatment and at the start of each treatment cycle

Sponsors & Collaborators

  • Steven Isakoff, MD, PhD

    lead OTHER

Principal Investigators

  • Steven Isakoff, MD, PhD · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2014-12-31
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00783757 on ClinicalTrials.gov